home / stock / dsnky / dsnky articles

DSNKY Articles, Daiichi Sankyo Co Ltd Sponsored ADR Level 1

Stock Information
Company Name: Daiichi Sankyo Co Ltd Sponsored ADR Level 1
Stock Symbol: DSNKY
Market: OTC
Menu
DSNKY DSNKY Quote DSNKY Short DSNKY News DSNKY Articles DSNKY Message Board
Get DSNKY Alerts

News, Short Squeeze, Breakout and More Instantly...
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug | Benzinga

On Wednesday, the FDA issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) seeking accelerated approval of Daiichi S...
Why Is AstraZeneca Stock Trading Lower On Tuesday? | Benzinga

On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population...

Double Good News For AstraZeneca's Breast Cancer Drugs | Benzinga

AstraZeneca plc (NASDAQ:AZN) reported topline data from a metastatic breast cancer treatment study. The results showed that Enhertu (t...

AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor | Benzinga

On Friday, the FDA approved Daiichi Sankyo Ltd’s (OTC:DSKYF) (OTC:DSNKY) and AstraZeneca Plc’s (NASDAQ:AZN) Enhertu...
What's Going On With Pfizer Stock Today? | Benzinga

Pfizer Inc (NYSE:PFE) is set to announce its fourth quarter 2023 earnings next week on 30th January. The analysts expect the US pharma giant to re...

Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today | Benzinga

Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares are trading lower on Wednesday after the company announced a $125 million amendment to the c...

Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting | Benzinga

AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo (OTC: DSKYF) (OTC: DSNKY) released topline data from the TROPION-Bre...
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials | Benzinga

Daiichi Sankyo (OTC: DSKYF) (OTC: DSNKY) and AstraZeneca plc (NASDAQ: AZN) released initial results from the TROPION-Lung04 phase 1b...

Next 10